TreeWAS
Search
Variant clusters
Hospitalization Episode Statistics (HES)
Genetic variants: 36,212
Diagnostic terms: × 19,155
Association results: = 693,640,860
Self-Reported Statistics (SRS)
Genetic variants: 28,458
Diagnostic terms: × 474
Association results: = 13,489,092
About
Frequently Asked Questions
Citation
Download association data
for this variant in csv format
Share this page

Variant-specific associations

rs72703193
log Bayes Factor = 5.14866
Chromosome 5   position 914,309  (GRCh37) Explore rs72703193 on Ensembl!

Hospitalization Episode Statistics (HES)

Self-Reported Statistics (SRS)

Hierarchical visualisation How to interpret this figure?
Associations at terminal nodes are shown if p(effect) ≥
Click here to show this figure without filtering.
Click on a node to zoom (except terminal nodes).
Download this figure in format
Results table
Term Risk
posterior probability
 No effect
posterior probability
 Protective
posterior probability
  
C76-C80 Malignant neoplasms of ill-defined, secondary and unspecified sites
1.000 0.000 0.000
# Top node
1.000 0.000 0.000
Chapter II Neoplasms
1.000 0.000 0.000
Chapter X Diseases of the respiratory system
1.000 0.000 0.000
Chapter XX External causes of morbidity and mortality
0.999 0.001 0.000
C78 Secondary malignant neoplasm of respiratory and digestive organs
0.998 0.002 0.000
Y40-Y59 Drugs, medicaments and biological substances causing adverse effects in therapeutic use
0.997 0.003 0.000
Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism
0.985 0.015 0.000
C79 Secondary malignant neoplasm of other sites
0.981 0.019 0.000
C78.7 Secondary malignant neoplasm of liver
0.981 0.019 0.000
Chapter XVII Congenital malformations, deformations and chromosomal abnormalities
0.972 0.028 0.000
J95-J99 Other diseases of the respiratory system
0.964 0.036 0.000
D70-D77 Other diseases of blood and blood-forming organs
0.961 0.039 0.000
Y43 Primarily systemic agents
0.952 0.048 0.000
C79.5 Secondary malignant neoplasm of bone and bone marrow
0.952 0.048 0.000
C80 Malignant neoplasm without specification of site
0.951 0.049 0.000
J30-J39 Other diseases of upper respiratory tract
0.950 0.050 0.000
C78.8 Secondary malignant neoplasm of other and unspecified digestive organs
0.949 0.051 0.000
J33 Nasal polyp
0.940 0.060 0.000
W20-W49 Exposure to inanimate mechanical forces
0.938 0.062 0.000
J09-J18 Influenza and pneumonia
0.933 0.067 0.000
J40-J47 Chronic lower respiratory diseases
0.933 0.067 0.000
Y43.3 Other antineoplastic drugs
0.929 0.071 0.000
J33.9 Nasal polyp, unspecified
0.928 0.072 0.000
D73 Diseases of spleen
0.925 0.075 0.000
J98 Other respiratory disorders
0.921 0.079 0.000
J90-J94 Other diseases of pleura
0.912 0.088 0.000
C81-C96 Malignant neoplasms, stated or presumed to be primary, of lymphoid, haematopoietic and related tissue
0.910 0.090 0.000
J60-J70 Lung diseases due to external agents
0.899 0.101 0.000
D65-D69 Coagulation defects, purpura and other haemorrhagic conditions
0.892 0.108 0.000
D73.0 Hyposplenism
0.892 0.108 0.000
D70 Agranulocytosis
0.890 0.110 0.000
X20-X29 Contact with venomous animals and plants
0.887 0.113 0.000
Chapter XII Diseases of the skin and subcutaneous tissue
0.885 0.115 0.000
C80.0 Malignant neoplasm, primary site unknown, so stated
0.883 0.117 0.000
W25 Contact with sharp glass
0.870 0.130 0.000
C78.5 Secondary malignant neoplasm of large intestine and rectum
0.869 0.131 0.000
C79.9 Secondary malignant neoplasm, unspecified site
0.868 0.132 0.000
Q38-Q45 Other congenital malformations of the digestive system
0.865 0.135 0.000
C78.0 Secondary malignant neoplasm of lung
0.863 0.137 0.000
J98.4 Other disorders of lung
0.862 0.138 0.000
Q80-Q89 Other congenital malformations
0.853 0.147 0.000
Chapter I Certain infectious and parasitic diseases
0.847 0.153 0.000
C43-C44 Melanoma and other malignant neoplasms of skin
0.846 0.154 0.000
Y52 Agents primarily affecting the cardiovascular system
0.845 0.155 0.000
J95 Postprocedural respiratory disorders, not elsewhere classified
0.842 0.158 0.000
J40 Bronchitis, not specified as acute or chronic
0.839 0.161 0.000
D69 Purpura and other haemorrhagic conditions
0.835 0.165 0.000
C82 Follicular [nodular] non-Hodgkin's lymphoma
0.834 0.166 0.000
N13 Obstructive and reflux uropathy
0.834 0.166 0.000
N10-N16 Renal tubulo-interstitial diseases
0.833 0.167 0.000
Chapter XIV Diseases of the genitourinary system
0.831 0.169 0.000
Y45 Analgesics, antipyretics and anti-inflammatory drugs
0.831 0.169 0.000
C73-C75 Malignant neoplasms of thyroid and other endocrine glands
0.825 0.175 0.000
N13.3 Other and unspecified hydronephrosis
0.822 0.178 0.000
W25.9 Unspecified place
0.821 0.179 0.000
C15-C26 Malignant neoplasms of digestive organs
0.812 0.188 0.000
C80.9 Malignant neoplasm, unspecified
0.812 0.188 0.000
J33.8 Other polyp of sinus
0.811 0.189 0.000
J90 Pleural effusion, not elsewhere classified
0.809 0.191 0.000
Y53 Agents primarily affecting the gastro-intestinal system
0.809 0.191 0.000
J42 Unspecified chronic bronchitis
0.809 0.191 0.000
C18 Malignant neoplasm of colon
0.809 0.191 0.000
J46 Status asthmaticus
0.806 0.194 0.000
X23 Contact with hornets, wasps and bees
0.806 0.194 0.000
Y40 Systemic antibiotics
0.806 0.194 0.000
L80-L99 Other disorders of the skin and subcutaneous tissue
0.805 0.195 0.000
Y41 Other systemic anti-infectives and antiparasitics
0.804 0.196 0.000
C43 Malignant melanoma of skin
0.801 0.199 0.000
J92 Pleural plaque
0.799 0.201 0.000
C79.6 Secondary malignant neoplasm of ovary
0.798 0.202 0.000
Y56 Topical agents primarily affecting skin and mucous membrane and ophthalmological, otorhinolaryngological and dental drugs
0.798 0.202 0.000
Y42 Hormones and their synthetic substitutes and antagonists, not elsewhere classified
0.797 0.203 0.000
Q60-Q64 Congenital malformations of the urinary system
0.797 0.203 0.000
C79.4 Secondary malignant neoplasm of other and unspecified parts of nervous system
0.796 0.204 0.000
C00-C14 Malignant neoplasms of lip, oral cavity and pharynx
0.796 0.204 0.000
Y90-Y98 Supplementary factors related to causes of morbidity and mortality classified elsewhere
0.788 0.212 0.000
X50-X57 Overexertion, travel and privation
0.787 0.213 0.000
Y54 Agents primarily affecting water-balance and mineral and uric acid metabolism
0.784 0.216 0.000
J61 Pneumoconiosis due to asbestos and other mineral fibres
0.782 0.218 0.000
N13.4 Hydroureter
0.781 0.219 0.000
C97-C97 Malignant neoplasms of independent (primary) multiple sites
0.777 0.223 0.000
J43 Emphysema
0.777 0.223 0.000
L20-L30 Dermatitis and eczema
0.777 0.223 0.000
N99-N99 Other disorders of the genitourinary system
0.775 0.225 0.000
J10 Influenza due to identified influenza virus
0.774 0.226 0.000
J15 Bacterial pneumonia, not elsewhere classified
0.772 0.228 0.000
A30-A49 Other bacterial diseases
0.772 0.228 0.000
C18.2 Ascending colon
0.771 0.229 0.000
J80-J84 Other respiratory diseases principally affecting the interstitium
0.769 0.231 0.000
X60-X84 Intentional self-harm
0.769 0.231 0.000
J32 Chronic sinusitis
0.769 0.231 0.000
C81 Hodgkin's disease
0.768 0.232 0.000
Y49 Psychotropic drugs, not elsewhere classified
0.768 0.232 0.000
J11 Influenza, virus not identified
0.767 0.233 0.000
Y51 Drugs primarily affecting the autonomic nervous system
0.767 0.233 0.000
Q85 Phakomatoses, not elsewhere classified
0.766 0.234 0.000
C51-C58 Malignant neoplasms of female genital organs
0.766 0.234 0.000
L81 Other disorders of pigmentation
0.764 0.236 0.000
Chapter XXII Codes for special purposes
0.762 0.238 0.000
Q65-Q79 Congenital malformations and deformations of the musculoskeletal system
0.762 0.238 0.000
X10-X19 Contact with heat and hot substances
0.761 0.239 0.000
C45-C49 Malignant neoplasms of mesothelial and soft tissue
0.761 0.239 0.000
W22 Striking against or struck by other objects
0.760 0.240 0.000
J13 Pneumonia due to Streptococcus pneumoniae
0.760 0.240 0.000
Y46 Antiepileptics and anti-Parkinsonism drugs
0.759 0.241 0.000
L98 Other disorders of skin and subcutaneous tissue, not elsewhere classified
0.756 0.244 0.000
J31 Chronic rhinitis, nasopharyngitis and pharyngitis
0.755 0.245 0.000
D60-D64 Aplastic and other anaemias
0.752 0.248 0.000
Q10-Q18 Congenital malformations of eye, ear, face and neck
0.751 0.249 0.000
V20-V29 Motorcycle rider injured in transport accident
0.750 0.250 0.000
X23.9 Unspecified place
0.748 0.251 0.000
Q50-Q56 Congenital malformations of genital organs
0.748 0.252 0.000
J98.6 Disorders of diaphragm
0.748 0.252 0.000
L81.4 Other melanin hyperpigmentation
0.745 0.255 0.000
J91 Pleural effusion in conditions classified elsewhere
0.740 0.260 0.000
N11 Chronic tubulo-interstitial nephritis
0.739 0.261 0.000
Q00-Q07 Congenital malformations of the nervous system
0.737 0.262 0.000
C79.0 Secondary malignant neoplasm of kidney and renal pelvis
0.735 0.264 0.000
N99 Postprocedural disorders of genito-urinary system, not elsewhere classified
0.734 0.266 0.000
C85 Other and unspecified types of non-Hodgkin's lymphoma
0.733 0.266 0.000
C69-C72 Malignant neoplasms of eye, brain and other parts of central nervous system
0.730 0.270 0.000
N13.1 Hydronephrosis with ureteral stricture, not elsewhere classified
0.729 0.271 0.000
J69 Pneumonitis due to solids and liquids
0.729 0.271 0.000
D69.6 Thrombocytopenia, unspecified
0.727 0.273 0.000
W49 Exposure to other and unspecified inanimate mechanical forces
0.725 0.275 0.000
L85 Other epidermal thickening
0.725 0.275 0.000
D73.5 Infarction of spleen
0.724 0.276 0.000
D55-D59 Haemolytic anaemias
0.723 0.277 0.000
Y52.4 Angiotensin-converting-enzyme inhibitors
0.722 0.278 0.000
C91 Lymphoid leukaemia
0.720 0.280 0.000
W50-W64 Exposure to animate mechanical forces
0.719 0.281 0.000
C78.6 Secondary malignant neoplasm of retroperitoneum and peritoneum
0.719 0.281 0.000
D80-D89 Certain disorders involving the immune mechanism
0.718 0.282 0.000
D76 Certain diseases involving lymphoreticular tissue and reticulohistiocytic system
0.717 0.283 0.000
C76 Malignant neoplasm of other and ill-defined sites
0.717 0.283 0.000
C40-C41 Malignant neoplasms of bone and articular cartilage
0.717 0.283 0.000
Chapter XVI Certain conditions originating in the perinatal period
0.717 0.283 0.000
J98.0 Diseases of bronchus, not elsewhere classified
0.717 0.283 0.000
Y35-Y36 Legal intervention and operations of war
0.716 0.284 0.000
Y10-Y34 Event of undetermined intent
0.716 0.284 0.000
Y00-Y09 Assault
0.716 0.284 0.000
X85-X99 Assault
0.716 0.284 0.000
X58-X59 Accidental exposure to other and unspecified factors
0.716 0.284 0.000
X30-X39 Exposure to forces of nature
0.716 0.284 0.000
X00-X09 Exposure to smoke, fire and flames
0.716 0.284 0.000
W85-W99 Exposure to electric current, radiation and extreme ambient air temperature and pressure
0.716 0.284 0.000
W75-W84 Other accidental threats to breathing
0.716 0.284 0.000
W65-W74 Accidental drowning and submersion
0.716 0.284 0.000
V98-V99 Other and unspecified transport accidents
0.716 0.284 0.000
V95-V97 Air and space transport accidents
0.716 0.284 0.000
V90-V94 Water transport accidents
0.716 0.284 0.000
V70-V79 Bus occupant injured in transport accident
0.716 0.284 0.000
V60-V69 Occupant of heavy transport vehicle injured in transport accident
0.716 0.284 0.000
V50-V59 Occupant of pick-up truck or van injured in transport accident
0.716 0.284 0.000
V30-V39 Occupant of three-wheeled motor vehicle injured in transport accident
0.716 0.284 0.000
V01-V09 Pedestrian injured in transport accident
0.716 0.284 0.000
C78.3 Secondary malignant neoplasm of other and unspecified respiratory organs
0.716 0.284 0.000
C78.1 Secondary malignant neoplasm of mediastinum
0.716 0.284 0.000
Y60-Y69 Misadventures to patients during surgical and medical care
0.716 0.284 0.000
Y59 Other and unspecified vaccines and biological substances
0.715 0.285 0.000
Y58 Bacterial vaccines
0.715 0.285 0.000
Y55 Agents primarily acting on smooth and skeletal muscles and the respiratory system
0.715 0.285 0.000
Y50 Central nervous system stimulants, not elsewhere classified
0.715 0.285 0.000
Y48 Anaesthetics and therapeutic gases
0.715 0.285 0.000
Y47 Sedatives, hypnotics and antianxiety drugs
0.715 0.285 0.000
Y44 Agents primarily affecting blood constituents
0.713 0.287 0.000
C79.2 Secondary malignant neoplasm of skin
0.712 0.288 0.000
W29 Contact with other powered hand tools and household machinery
0.712 0.288 0.000
C78.4 Secondary malignant neoplasm of small intestine
0.711 0.289 0.000
C18.3 Hepatic flexure
0.708 0.291 0.000
Q38 Other congenital malformations of tongue, mouth and pharynx
0.708 0.291 0.000
C43.4 Malignant melanoma of scalp and neck
0.707 0.293 0.000
Y43.0 Antiallergic and antiemetic drugs
0.706 0.294 0.000
C43.5 Malignant melanoma of trunk
0.706 0.294 0.000
J17 Pneumonia in diseases classified elsewhere
0.705 0.295 0.000
Q44 Congenital malformations of gallbladder, bile ducts and liver
0.705 0.295 0.000
Q85.0 Neurofibromatosis (nonmalignant)
0.704 0.296 0.000
V40-V49 Car occupant injured in transport accident
0.704 0.296 0.000
A41 Other septicaemia
0.703 0.297 0.000
V80-V89 Other land transport accidents
0.702 0.298 0.000
N13.5 Kinking and stricture of ureter without hydronephrosis
0.701 0.299 0.000
C30-C39 Malignant neoplasms of respiratory and intrathoracic organs
0.700 0.300 0.000
C18.7 Sigmoid colon
0.700 0.300 0.000
C73 Malignant neoplasm of thyroid gland
0.699 0.301 0.000
L50-L54 Urticaria and erythema
0.699 0.301 0.000
C79.1 Secondary malignant neoplasm of bladder and other and unspecified urinary organs
0.699 0.301 0.000
Q90-Q99 Chromosomal abnormalities, not elsewhere classified
0.697 0.303 0.000
Q35-Q37 Cleft lip and cleft palate
0.697 0.303 0.000
Q30-Q34 Congenital malformations of the respiratory system
0.697 0.303 0.000
J36 Peritonsillar abscess
0.697 0.303 0.000
N17-N19 Renal failure
0.695 0.305 0.000
D63 Anaemia in chronic diseases classified elsewhere
0.694 0.306 0.000
B20-B24 Human immunodeficiency virus [HIV] disease
0.694 0.306 0.000
C18.0 Caecum
0.694 0.306 0.000
Y85-Y89 Sequelae of external causes of morbidity and mortality
0.693 0.307 0.000
C82.1 Mixed small cleaved and large cell, follicular
0.692 0.307 0.000
J96 Respiratory failure, not elsewhere classified
0.691 0.309 0.000
J95.9 Postprocedural respiratory disorder, unspecified
0.690 0.310 0.000
D74 Methaemoglobinaemia
0.689 0.311 0.000
D77 Other disorders of blood and blood-forming organs in diseases classified elsewhere
0.689 0.311 0.000
D71 Functional disorders of polymorphonuclear neutrophils
0.689 0.311 0.000
N99.8 Other postprocedural disorders of genito-urinary system
0.686 0.314 0.000
Y52.5 Other antihypertensive drugs, not elsewhere classified
0.686 0.314 0.000
L27 Dermatitis due to substances taken internally
0.686 0.314 0.000
C79.7 Secondary malignant neoplasm of adrenal gland
0.685 0.315 0.000
Y43.9 Primarily systemic agent, unspecified
0.683 0.317 0.000
Y43.8 Other primarily systemic agents, not elsewhere classified
0.683 0.317 0.000
Y43.6 Enzymes, not elsewhere classified
0.683 0.317 0.000
Y43.5 Acidifying and alkalising agents
0.683 0.317 0.000
Y43.2 Antineoplastic natural products
0.683 0.317 0.000
Q39 Congenital malformations of oesophagus
0.682 0.318 0.000
J32.9 Chronic sinusitis, unspecified
0.681 0.319 0.000
Q60 Renal agenesis and other reduction defects of kidney
0.681 0.319 0.000
J98.1 Pulmonary collapse
0.679 0.321 0.000
D69.3 Idiopathic thrombocytopenic purpura
0.679 0.321 0.000
B15-B19 Viral hepatitis
0.676 0.323 0.000
J44 Other chronic obstructive pulmonary disease
0.675 0.325 0.000
Y53.4 Other laxatives
0.674 0.325 0.000
J33.1 Polypoid sinus degeneration
0.674 0.326 0.000
L98.8 Other specified disorders of skin and subcutaneous tissue
0.674 0.326 0.000
W46 Contact with hypodermic needle
0.672 0.327 0.000
W45 Foreign body or object entering through skin
0.672 0.327 0.000
W43 Exposure to vibration
0.672 0.327 0.000
W42 Exposure to noise
0.672 0.327 0.000
W41 Exposure to high-pressure jet
0.672 0.327 0.000
W40 Explosion of other materials
0.672 0.327 0.000
W39 Discharge of firework
0.672 0.327 0.000
W38 Explosion and rupture of other specified pressurised devices
0.672 0.327 0.000
W37 Explosion and rupture of pressurised tyre, pipe or hose
0.672 0.327 0.000
W36 Explosion and rupture of gas cylinder
0.672 0.327 0.000
W35 Explosion and rupture of boiler
0.672 0.327 0.000
W34 Discharge from other and unspecified firearms
0.672 0.327 0.000
W33 Rifle, shotgun and larger firearm discharge
0.672 0.327 0.000
W32 Handgun discharge
0.672 0.327 0.000
W31 Contact with other and unspecified machinery
0.672 0.327 0.000
W30 Contact with agricultural machinery
0.672 0.327 0.000
W28 Contact with powered lawn mower
0.672 0.327 0.000
W27 Contact with nonpowered hand tool
0.672 0.327 0.000
W26 Contact with knife, sword or dagger
0.672 0.327 0.000
W24 Contact with lifting and transmission devices, not elsewhere classified
0.672 0.327 0.000
W23 Caught, crushed, jammed or pinched in or between objects
0.672 0.327 0.000
W20 Struck by thrown, projected or falling object
0.672 0.327 0.000
Y45.0 Opioids and related analgesics
0.672 0.328 0.000
C50-C50 Malignant neoplasm of breast
0.672 0.328 0.000
Y43.1 Antineoplastic antimetabolites
0.672 0.328 0.000
Y70-Y82 Medical devices associated with adverse incidents in diagnostic and therapeutic use
0.670 0.330 0.000
J92.0 Pleural plaque with presence of asbestos
0.670 0.330 0.000
Y40.9 Systemic antibiotic, unspecified
0.670 0.330 0.000
D69.9 Haemorrhagic condition, unspecified
0.670 0.330 0.000
C82.9 Follicular non-Hodgkin's lymphoma, unspecified
0.669 0.330 0.000
J16 Pneumonia due to other infectious organisms, not elsewhere classified
0.669 0.331 0.000
J12 Viral pneumonia, not elsewhere classified
0.669 0.331 0.000
J09 Influenza due to certain identified influenza virus
0.669 0.331 0.000
J41 Simple and mucopurulent chronic bronchitis
0.669 0.331 0.000
W21 Striking against or struck by sports equipment
0.667 0.332 0.000
J98.8 Other specified respiratory disorders
0.667 0.333 0.000
J85-J86 Suppurative and necrotic conditions of lower respiratory tract
0.666 0.334 0.000
Y41.8 Other specified systemic anti-infectives and antiparasitics
0.666 0.334 0.000
C60-C63 Malignant neoplasms of male genital organs
0.665 0.335 0.000
J43.9 Emphysema, unspecified
0.665 0.335 0.000
Chapter IV Endocrine, nutritional and metabolic diseases
0.665 0.335 0.000
J37 Chronic laryngitis and laryngotracheitis
0.664 0.336 0.000
C82.2 Large cell, follicular
0.663 0.336 0.000
J67 Hypersensitivity pneumonitis due to organic dust
0.663 0.336 0.000
D73.9 Disease of spleen, unspecified
0.663 0.336 0.000
D73.8 Other diseases of spleen
0.663 0.336 0.000
D73.4 Cyst of spleen
0.663 0.336 0.000
D73.3 Abscess of spleen
0.663 0.336 0.000
D73.2 Chronic congestive splenomegaly
0.663 0.336 0.000
D73.1 Hypersplenism
0.663 0.336 0.000
J95.0 Tracheostomy malfunction
0.663 0.337 0.000
C18.5 Splenic flexure
0.661 0.339 0.000
A41.9 Septicaemia, unspecified
0.661 0.339 0.000
J98.5 Diseases of mediastinum, not elsewhere classified
0.660 0.340 0.000
J98.3 Compensatory emphysema
0.660 0.340 0.000
J98.2 Interstitial emphysema
0.660 0.340 0.000
J10.1 Influenza with other respiratory manifestations, influenza virus identified
0.659 0.341 0.000
D63.0 Anaemia in neoplastic disease
0.659 0.341 0.000
J92.9 Pleural plaque without asbestos
0.658 0.341 0.000
J95.8 Other postprocedural respiratory disorders
0.658 0.342 0.000
C18.4 Transverse colon
0.657 0.343 0.000
D69.0 Allergic purpura
0.657 0.343 0.000
Y56.0 Local antifungal, anti-infective and anti-inflammatory drugs, not elsewhere classified
0.655 0.345 0.000
L85.9 Epidermal thickening, unspecified
0.655 0.345 0.000
C84 Peripheral and cutaneous T-cell lymphomas
0.653 0.347 0.000
C96 Other and unspecified malignant neoplasms of lymphoid, haematopoietic and related tissue
0.653 0.347 0.000
C95 Leukaemia of unspecified cell type
0.653 0.347 0.000
C94 Other leukaemias of specified cell type
0.653 0.347 0.000
C93 Monocytic leukaemia
0.653 0.347 0.000
C86 Other specified types of T/NK-cell lymphoma
0.653 0.347 0.000
C82.0 Small cleaved cell, follicular
0.653 0.347 0.000
C09 Malignant neoplasm of tonsil
0.652 0.348 0.000
C17 Malignant neoplasm of small intestine
0.652 0.348 0.000
Y42.5 Other oestrogens and progestogens
0.651 0.349 0.000
C48 Malignant neoplasm of retroperitoneum and peritoneum
0.651 0.349 0.000
Q64 Other congenital malformations of urinary system
0.650 0.350 0.000
Y91 Evidence of alcohol involvement determined by level of intoxication
0.648 0.352 0.000
J11.1 Influenza with other respiratory manifestations, virus not identified
0.648 0.352 0.000
L98.0 Pyogenic granuloma
0.647 0.353 0.000
C90 Multiple myeloma and malignant plasma cell neoplasms
0.646 0.354 0.000
J70 Respiratory conditions due to other external agents
0.644 0.355 0.000
J68 Respiratory conditions due to inhalation of chemicals, gases, fumes and vapours
0.644 0.355 0.000
J66 Airway disease due to specific organic dust
0.644 0.355 0.000
J63 Pneumoconiosis due to other inorganic dusts
0.644 0.355 0.000
J62 Pneumoconiosis due to dust containing silica
0.644 0.355 0.000
J65 Pneumoconiosis associated with tuberculosis
0.644 0.355 0.000
J64 Unspecified pneumoconiosis
0.644 0.355 0.000
J60 Coalworker's pneumoconiosis
0.644 0.355 0.000
B50-B64 Protozoal diseases
0.644 0.356 0.000
Y40.3 Macrolides
0.644 0.356 0.000
B90-B94 Sequelae of infectious and parasitic diseases
0.644 0.356 0.000
J44.1 Chronic obstructive pulmonary disease with acute exacerbation, unspecified
0.642 0.358 0.000
C88 Malignant immunoproliferative diseases
0.642 0.358 0.000
N11.9 Chronic tubulo-interstitial nephritis, unspecified
0.641 0.359 0.000
C55 Malignant neoplasm of uterus, part unspecified
0.640 0.360 0.000
C07 Malignant neoplasm of parotid gland
0.640 0.360 0.000
D67 Hereditary factor IX deficiency
0.640 0.360 0.000
D66 Hereditary factor VIII deficiency
0.640 0.360 0.000
D65 Disseminated intravascular coagulation [defibrination syndrome]
0.640 0.360 0.000
L83 Acanthosis nigricans
0.639 0.361 0.000
C85.9 Non-Hodgkin's lymphoma, unspecified type
0.639 0.361 0.000
J18 Pneumonia, organism unspecified
0.639 0.361 0.000
J33.0 Polyp of nasal cavity
0.637 0.363 0.000
X29 Contact with unspecified venomous animal or plant
0.636 0.364 0.000
X28 Contact with other specified venomous plants
0.636 0.364 0.000
X27 Contact with other specified venomous animals
0.636 0.364 0.000
X26 Contact with venomous marine animals and plants
0.636 0.364 0.000
X25 Contact with other specified venomous arthropods
0.636 0.364 0.000
X24 Contact with centipedes and venomous millipedes (tropical)
0.636 0.364 0.000
X22 Contact with scorpions
0.636 0.364 0.000
X21 Contact with venomous spiders
0.636 0.364 0.000
X20 Contact with venomous snakes and lizards
0.636 0.364 0.000
J39 Other diseases of upper respiratory tract
0.636 0.364 0.000
Q82 Other congenital malformations of skin
0.635 0.365 0.000
L10-L14 Bullous disorders
0.634 0.365 0.000
C81.2 Mixed cellularity
0.634 0.366 0.000
J32.2 Chronic ethmoidal sinusitis
0.634 0.366 0.000
Chapter VIII Diseases of the ear and mastoid process
0.633 0.367 0.000
W22.9 Unspecified place
0.633 0.367 0.000
Y57 Other and unspecified drugs and medicaments
0.632 0.367 0.000
J30 Vasomotor and allergic rhinitis
0.632 0.368 0.000
J98.9 Respiratory disorder, unspecified
0.632 0.368 0.000
Y54.3 Benzothiadiazine derivatives
0.631 0.368 0.000
C43.3 Malignant melanoma of other and unspecified parts of face
0.631 0.369 0.000
Y45.3 Other nonsteroidal anti-inflammatory drugs [NSAID]
0.631 0.369 0.000
C43.6 Malignant melanoma of upper limb, including shoulder
0.631 0.369 0.000
C64-C68 Malignant neoplasms of urinary tract
0.630 0.370 0.000
N13.9 Obstructive and reflux uropathy, unspecified
0.629 0.371 0.000
A40 Streptococcal septicaemia
0.628 0.372 0.000
V10-V19 Pedal cyclist injured in transport accident
0.627 0.373 0.000
A80-A89 Viral infections of the central nervous system
0.627 0.373 0.000
C79.3 Secondary malignant neoplasm of brain and cerebral meninges
0.625 0.375 0.000
J15.7 Pneumonia due to Mycoplasma pneumoniae
0.624 0.375 0.000
W25.6 Industrial and construction area
0.624 0.376 0.000
W25.5 Trade and service area
0.624 0.376 0.000
W25.1 Residential institution
0.624 0.376 0.000
W25.0 Home
0.624 0.376 0.000
W25.8 Other specified place
0.624 0.376 0.000
W25.7 Farm
0.624 0.376 0.000
W25.4 Street and highway
0.624 0.376 0.000
W25.3 Sports and athletics area
0.624 0.376 0.000
W25.2 School, other institution and public administrative area
0.624 0.376 0.000
N13.6 Pyonephrosis
0.623 0.377 0.000
B99-B99 Other infectious diseases
0.622 0.378 0.000
A41.5 Septicaemia due to other Gram-negative organisms
0.621 0.379 0.000
Q43 Other congenital malformations of intestine
0.620 0.379 0.000
L27.0 Generalised skin eruption due to drugs and medicaments
0.620 0.379 0.000
Q45 Other congenital malformations of digestive system
0.620 0.380 0.000
Q42 Congenital absence, atresia and stenosis of large intestine
0.620 0.380 0.000
Q41 Congenital absence, atresia and stenosis of small intestine
0.620 0.380 0.000
Q40 Other congenital malformations of upper alimentary tract
0.620 0.380 0.000
D86 Sarcoidosis
0.619 0.381 0.000
Y42.3 Insulin and oral hypoglycaemic [antidiabetic] drugs
0.619 0.381 0.000
J84 Other interstitial pulmonary diseases
0.618 0.382 0.000
N17 Acute renal failure
0.618 0.382 0.000
C97 Malignant neoplasms of independent (primary) multiple sites
0.617 0.383 0.000
L89 Decubitus ulcer
0.616 0.384 0.000
N25-N29 Other disorders of kidney and ureter
0.616 0.384 0.000
N99.3 Prolapse of vaginal vault after hysterectomy
0.615 0.385 0.000
L55-L59 Radiation-related disorders of the skin and subcutaneous tissue
0.614 0.386 0.000
Y45.2 Propionic acid derivatives
0.614 0.386 0.000
J94 Other pleural conditions
0.612 0.388 0.000
Q86 Congenital malformation syndromes due to known exogenous causes, not elsewhere classified
0.612 0.388 0.000
Q84 Other congenital malformations of integument
0.612 0.388 0.000
Q83 Congenital malformations of breast
0.612 0.388 0.000
Q81 Epidermolysis bullosa
0.612 0.388 0.000
Q80 Congenital ichthyosis
0.612 0.388 0.000
L95 Vasculitis limited to skin, not elsewhere classified
0.611 0.388 0.000
Q66 Congenital deformities of feet
0.611 0.389 0.000
J31.0 Chronic rhinitis
0.610 0.390 0.000
C05 Malignant neoplasm of palate
0.610 0.390 0.000
J14 Pneumonia due to Haemophilus influenzae
0.610 0.390 0.000
J99 Respiratory disorders in diseases classified elsewhere
0.609 0.391 0.000
L23 Allergic contact dermatitis
0.609 0.391 0.000
L80 Vitiligo
0.608 0.392 0.000
Y52.1 Calcium-channel blockers
0.608 0.392 0.000
B85-B89 Pediculosis, acariasis and other infestations
0.607 0.392 0.000
A92-A99 Arthropod-borne viral fevers and viral haemorrhagic fevers
0.607 0.392 0.000
A75-A79 Rickettsioses
0.607 0.392 0.000
A70-A74 Other diseases caused by chlamydiae
0.607 0.392 0.000
A65-A69 Other spirochaetal diseases
0.607 0.392 0.000
A20-A28 Certain zoonotic bacterial diseases
0.607 0.392 0.000
A15-A19 Tuberculosis
0.607 0.392 0.000
J69.0 Pneumonitis due to food and vomit
0.607 0.393 0.000
L28 Lichen simplex chronicus and prurigo
0.607 0.393 0.000
Y52.9 Other and unspecified agents primarily affecting the cardiovascular system
0.606 0.394 0.000
Y52.8 Antivaricose drugs, including sclerosing agents
0.606 0.394 0.000
Y52.7 Peripheral vasodilators
0.606 0.394 0.000
Y52.6 Antihyperlipidaemic and antiarteriosclerotic drugs
0.606 0.394 0.000
Y52.0 Cardiac-stimulant glycosides and drugs of similar action
0.606 0.394 0.000
Y45.1 Salicylates
0.606 0.394 0.000
X62 Intentional self-poisoning by and exposure to narcotics and psychodysleptics [hallucinogens], not elsewhere classified
0.606 0.394 0.000
B25-B34 Other viral diseases
0.605 0.395 0.000
Y52.2 Other antidysrhythmic drugs, not elsewhere classified
0.605 0.395 0.000
C43.9 Malignant melanoma of skin, unspecified
0.604 0.396 0.000
X50 Overexertion and strenuous or repetitive movements
0.604 0.396 0.000
Y49.2 Other and unspecified antidepressants
0.603 0.396 0.000
J95.5 Postprocedural subglottic stenosis
0.603 0.396 0.000
J95.4 Mendelson's syndrome
0.603 0.396 0.000
J95.3 Chronic pulmonary insufficiency following surgery
0.603 0.396 0.000
J95.2 Acute pulmonary insufficiency following nonthoracic surgery
0.603 0.396 0.000
J95.1 Acute pulmonary insufficiency following thoracic surgery
0.603 0.396 0.000
D68 Other coagulation defects
0.603 0.396 0.000
Q89 Other congenital malformations, not elsewhere classified
0.603 0.397 0.000
E20-E35 Disorders of other endocrine glands
0.603 0.397 0.000
B65-B83 Helminthiases
0.602 0.398 0.000
D72 Other disorders of white blood cells
0.602 0.398 0.000
Y51.7 Beta-Adrenoreceptor antagonists, not elsewhere classified
0.601 0.398 0.000
X51 Travel and motion
0.601 0.399 0.000
C77 Secondary and unspecified malignant neoplasm of lymph nodes
0.601 0.399 0.000
C81.1 Nodular sclerosis
0.600 0.400 0.000
Q87 Other specified congenital malformation syndromes affecting multiple systems
0.600 0.400 0.000
D69.8 Other specified haemorrhagic conditions
0.598 0.401 0.000
D69.4 Other primary thrombocytopenia
0.598 0.401 0.000
D69.2 Other nonthrombocytopenic purpura
0.598 0.401 0.000
D69.1 Qualitative platelet defects
0.598 0.401 0.000
C82.7 Other types of follicular non-Hodgkin's lymphoma
0.598 0.402 0.000
C82.6 Cutaneous follicle centre lymphoma
0.598 0.402 0.000
C82.5 Diffuse follicle centre lymphoma
0.598 0.402 0.000
C82.4 Follicular lymphoma grade IIIb
0.598 0.402 0.000
C82.3 Follicular lymphoma grade IIIa
0.598 0.402 0.000
N13.7 Vesicoureteral-reflux-associated uropathy
0.598 0.402 0.000
N19 Unspecified renal failure
0.598 0.402 0.000
Q60.0 Renal agenesis, unilateral
0.597 0.403 0.000
L21 Seborrhoeic dermatitis
0.597 0.403 0.000
N16 Renal tubulo-interstitial disorders in diseases classified elsewhere
0.597 0.403 0.000
N15 Other renal tubulo-interstitial diseases
0.597 0.403 0.000
N14 Drug- and heavy-metal-induced tubulo-interstitial and tubular conditions
0.597 0.403 0.000
N11.1 Chronic obstructive pyelonephritis
0.597 0.403 0.000
D37-D48 Neoplasms of uncertain or unknown behaviour
0.596 0.404 0.000
Q38.7 Pharyngeal pouch
0.596 0.404 0.000
Y45.9 Analgesic, antipyretic and anti-inflammatory drug, unspecified
0.596 0.404 0.000
Y45.8 Other analgesics and antipyretics
0.596 0.404 0.000
Y45.5 4-Aminophenol derivatives
0.596 0.404 0.000
Y45.4 Antirheumatics
0.596 0.404 0.000
J15.1 Pneumonia due to Pseudomonas
0.595 0.405 0.000
J32.0 Chronic maxillary sinusitis
0.594 0.406 0.000
J15.0 Pneumonia due to Klebsiella pneumoniae
0.594 0.406 0.000
Q18 Other congenital malformations of face and neck
0.592 0.408 0.000
X68 Intentional self-poisoning by and exposure to pesticides
0.592 0.408 0.000
C75 Malignant neoplasm of other endocrine glands and related structures
0.591 0.409 0.000
C74 Malignant neoplasm of adrenal gland
0.591 0.409 0.000
X10 Contact with hot drinks, food, fats and cooking oils
0.591 0.409 0.000
L40-L45 Papulosquamous disorders
0.591 0.409 0.000
Chapter XIX Injury, poisoning and certain other consequences of external causes
0.590 0.410 0.000
Q44.6 Cystic disease of liver
0.590 0.410 0.000
U82-U85 Resistance to antimicrobial and antineoplastic drugs
0.589 0.411 0.000
Y46.4 Iminostilbenes
0.589 0.411 0.000
E10-E14 Diabetes mellitus
0.587 0.413 0.000
J35 Chronic diseases of tonsils and adenoids
0.586 0.414 0.000
C18.1 Appendix
0.585 0.415 0.000
C91.9 Lymphoid leukaemia, unspecified
0.585 0.415 0.000
B24 Unspecified human immunodeficiency virus [HIV] disease
0.585 0.415 0.000
C24 Malignant neoplasm of other and unspecified parts of biliary tract
0.582 0.417 0.000
C23 Malignant neoplasm of gallbladder
0.582 0.417 0.000
L98.4 Chronic ulcer of skin, not elsewhere classified
0.582 0.418 0.000
Y53.9 Agent primarily affecting the gastro-intestinal system, unspecified
0.580 0.420 0.000
Y53.8 Other agents primarily affecting the gastro-intestinal system
0.580 0.420 0.000
Y53.7 Emetics
0.580 0.420 0.000
Y53.6 Antidiarrhoeal drugs
0.580 0.420 0.000
Y53.5 Digestants
0.580 0.420 0.000
Y53.3 Saline and osmotic laxatives
0.580 0.420 0.000
Y53.2 Stimulant laxatives
0.580 0.420 0.000
Y53.1 Other antacids and anti-gastric-secretion drugs
0.580 0.420 0.000
Y53.0 Histamine H2-receptor antagonists
0.580 0.420 0.000
C18.8 Overlapping lesion of colon
0.580 0.420 0.000
Q63 Other congenital malformations of kidney
0.579 0.420 0.000
B00-B09 Viral infections characterized by skin and mucous membrane lesions
0.578 0.422 0.000
X23.8 Other specified place
0.578 0.422 0.000
X23.7 Farm
0.578 0.422 0.000
X23.6 Industrial and construction area
0.578 0.422 0.000
X23.5 Trade and service area
0.578 0.422 0.000
X23.4 Street and highway
0.578 0.422 0.000
X23.3 Sports and athletics area
0.578 0.422 0.000
X23.2 School, other institution and public administrative area
0.578 0.422 0.000
X23.1 Residential institution
0.578 0.422 0.000
X23.0 Home
0.578 0.422 0.000
Y40.7 Antifungal antibiotics, systemically used
0.578 0.422 0.000
Y40.6 Rifamycins
0.578 0.422 0.000

This table lists the top 500 terms ordered by p(effect).

The full results table can be downloaded from this page.

 

The TreeWAS Database is the result of research conducted at the Oxford Big Data Institute at the University of Oxford.

This research has been conducted using the UK Biobank Resource (application number 10625). This work uses data provided by patients and collected by the NHS as part of their care and support.

This research has been conducted with the support of the Wellcome Trust (100956/Z/13/Z and 090532/Z/09/Z and 100308/Z/12/Z), the Danish National Research Foundation, Takeda, the Medical Research Council (MC_UU_12010/3), the Oak Foundation (OCAY-15-520), the National Institute for Health Research (NIHR) Oxford Biomedical Research Centre (BRC), the Wellcome Trust/Royal Society (204290/Z/16/Z) and the Li Ka Shing Foundation.

This website was created, designed, and edited by ORCID iD iconPatrick K. Albers

The contents of TreeWAS.org are available under the Creative Commons Attribution 4.0 International License (CC BY 4.0) with attribution (citation) required.

TreeWAS Database © 2019 - 2024 About Frequently Asked Questions Citation Contact Terms & Conditions This website does not use cookies to collect any personal information about you.